Literature DB >> 29097226

Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.

Katie L Cavanagh1, Chinmay Maheshwari1, Naír Rodríguez-Hornedo2.   

Abstract

This work challenges the popular notion that pharmaceutical salts are more soluble than cocrystals. There are cocrystals that are more soluble than salt forms of a drug and vice-versa. It all depends on the interplay between the chemistry of both the solid and solution phases. Aqueous solubility, pHmax, and supersaturation index (SA = SCC/SD or Ssalt/SD) of cocrystals and salts of a basic drug, lamotrigine (LTG), were determined, and mathematical models that predict the influence of cocrystal/salt Ksp and Ka were derived. Ksp and SA followed the order LTG-nicotinamide cocrystal (18) > LTG-HCl salt (12) > LTG-saccharin salt (5) > LTG-methylparaben cocrystal (1) > LTG-phenobarbital cocrystal (0.2). The values in parenthesis represent SA under nonionizing conditions. Cocrystal/salt solubility and thermodynamic stability are determined by pH and will drastically change with a single unit change in pH. pHmax values ranged from 5.0 (saccharin salt) to 6.4 (methylparaben cocrystal) to 9.0 (phenobarbital cocrystal). Cocrystal/salt pHmax dependence on pKsp and pKa shows that cocrystals and salts exhibit different behavior. Solubility and pHmax are as important as supersaturation index in assessing the stability and risks associated with conversions of supersaturating forms.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cocrystals; pH; poorly water-soluble drugs; salt disproportionation; salts/salt selection; solubility; supersaturation

Mesh:

Substances:

Year:  2017        PMID: 29097226      PMCID: PMC5774673          DOI: 10.1016/j.xphs.2017.10.033

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Determination of pKa values by capillary zone electrophoresis with a dynamic coating procedure.

Authors:  Laurent Geiser; Yveline Henchoz; Alexandra Galland; Pierre-Alain Carrupt; Jean-Luc Veuthey
Journal:  J Sep Sci       Date:  2005-11       Impact factor: 3.645

2.  Reaction crystallization of pharmaceutical molecular complexes.

Authors:  Naír Rodríguez-Hornedo; Sarah J Nehm; Kurt F Seefeldt; Yomaira Pagan-Torres; Christopher J Falkiewicz
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

Review 3.  Solubility: it's not just for physical chemists.

Authors:  Shobha N Bhattachar; Laura A Deschenes; James A Wesley
Journal:  Drug Discov Today       Date:  2006-09-26       Impact factor: 7.851

4.  Rapid throughput screening of apparent KSP values for weakly basic drugs using 96-well format.

Authors:  Jeremy Guo; Paul A Elzinga; Michael J Hageman; James N Herron
Journal:  J Pharm Sci       Date:  2008-06       Impact factor: 3.534

5.  The salt-cocrystal continuum: the influence of crystal structure on ionization state.

Authors:  Scott L Childs; G Patrick Stahly; Aeri Park
Journal:  Mol Pharm       Date:  2007-04-27       Impact factor: 4.939

Review 6.  Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.

Authors:  Gislaine Kuminek; Fengjuan Cao; Alanny Bahia de Oliveira da Rocha; Simone Gonçalves Cardoso; Naír Rodríguez-Hornedo
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

7.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.

Authors:  Scott L Childs; Leonard J Chyall; Jeanette T Dunlap; Valeriya N Smolenskaya; Barbara C Stahly; G Patrick Stahly
Journal:  J Am Chem Soc       Date:  2004-10-20       Impact factor: 15.419

Review 8.  Salt formation to improve drug solubility.

Authors:  Abu T M Serajuddin
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

9.  pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.

Authors:  Amjad Alhalaweh; Lilly Roy; Naír Rodríguez-Hornedo; Sitaram P Velaga
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

Review 10.  Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.

Authors:  David P Elder; René Holm; Heidi Lopez de Diego
Journal:  Int J Pharm       Date:  2012-11-24       Impact factor: 5.875

View more
  6 in total

1.  Multicomponent crystalline solid forms of aripiprazole produced via hot melt extrusion techniques: An exploratory study.

Authors:  Arun Butreddy; Mashan Almutairi; Neeraja Komanduri; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2021-04-20       Impact factor: 5.062

2.  Organic Salts of p-Coumaric Acid and Trans-Ferulic Acid with Aminopicolines.

Authors:  Sosthene Nyomba Kamanda; Ayesha Jacobs
Journal:  Molecules       Date:  2020-02-10       Impact factor: 4.411

3.  Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH.

Authors:  Jaydip M Vasoya; Ankita V Shah; Abu T M Serajuddin
Journal:  ADMET DMPK       Date:  2019-04-05

Review 4.  Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.

Authors:  Isabela Fanelli Barreto Biscaia; Samantha Nascimento Gomes; Larissa Sakis Bernardi; Paulo Renato Oliveira
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

5.  Dissolution Advantage of Nitazoxanide Cocrystals in the Presence of Cellulosic Polymers.

Authors:  Reynaldo Salas-Zúñiga; Christian Rodríguez-Ruiz; Herbert Höpfl; Hugo Morales-Rojas; Obdulia Sánchez-Guadarrama; Patricia Rodríguez-Cuamatzi; Dea Herrera-Ruiz
Journal:  Pharmaceutics       Date:  2019-12-25       Impact factor: 6.321

6.  Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.

Authors:  Hannes Lengauer; Damjan Makuc; Damjan Šterk; Franc Perdih; Arthur Pichler; Tina Trdan Lušin; Janez Plavec; Zdenko Časar
Journal:  Pharmaceutics       Date:  2020-04-10       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.